Terms: = Prostate cancer AND HOXC13, HOX3G, 3229, ENSG00000123364, P31276, HOX3
5 results:
1. Silencing hoxc13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway.
Li M; Bai G; Cen Y; Xie Q; Chen J; Chen J; Chen Q; Zhong W; Zhou X
J Transl Med; 2023 Dec; 21(1):884. PubMed ID: 38057852
[TBL] [Abstract] [Full Text] [Related]
2. The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms.
Mather RL; Parolia A; Carson SE; Venalainen E; Roig-Carles D; Jaber M; Chu SC; Alborelli I; Wu R; Lin D; Nabavi N; Jachetti E; Colombo MP; Xue H; Pucci P; Ci X; Hawkes C; Li Y; Pandha H; Ulitsky I; Marconett C; Quagliata L; Jiang W; Romero I; Wang Y; Crea F
Mol Oncol; 2021 Jul; 15(7):1921-1941. PubMed ID: 33793068
[TBL] [Abstract] [Full Text] [Related]
3. A four gene signature predictive of recurrent prostate cancer.
Komisarof J; McCall M; Newman L; Bshara W; Mohler JL; Morrison C; Land H
Oncotarget; 2017 Jan; 8(2):3430-3440. PubMed ID: 27966447
[TBL] [Abstract] [Full Text] [Related]
4. A 'One Stop' prostate Clinic for rural and remote men: a report on the first 200 patients.
McCombie SP; Hawks C; Emery JD; Hayne D
BJU Int; 2015 Oct; 116 Suppl 3():11-7. PubMed ID: 26218767
[TBL] [Abstract] [Full Text] [Related]
5. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
[TBL] [Abstract] [Full Text] [Related]
